TRVN - Trevena, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Trevena, Inc.

955 Chesterbrook Boulevard
Suite 200
Chesterbrook, PA 19087
United States
610-354-8840
http://www.trevenainc.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees51

Key Executives

NameTitlePayExercisedYear Born
Ms. Carrie L. BourdowCEO, Pres & DirectorN/AN/A1963
Dr. Howard A. Rockman M.D.Scientific Founder, Consultant and Member of Scientific Advisory BoardN/AN/AN/A
Dr. Jonathan Violin Ph.D.Sr. VP of Scientific Affairs & Investor Relations OfficerN/AN/A1975
Mr. John M. LimongelliChief Admin. Officer, Sr. VP, Gen. Counsel & Corp. Sec.457.48kN/A1970
Mr. Michael CatalanoVP of MarketingN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Trevena, Inc., a biopharmaceutical company, develops therapies based on breakthrough science to benefit patients and healthcare providers confronting serious medical conditions. Its product candidates include OLINVO injection, a G protein biased ligand of the µ opioid receptor that has completed Phase III clinical trials for the management of moderate-to-severe acute pain where intravenous administration is preferred; TRV250, a G protein biased ligand targeting the d-receptor, which is in Phase I clinical study for the treatment of migraine; and TRV734, a small molecule G protein biased ligand of the µ opioid receptor that has completed Phase I clinical study for the treatment of moderate-to-severe acute and chronic pain, as well as TRV027 for the treatment of acute heart failure. The company was founded in 2007 and is headquartered in Chesterbrook, Pennsylvania.

Corporate Governance

Trevena, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.